Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
149,003,213
-
Total 13F shares
-
199,223
-
Share change
-
+137,125
-
Total reported value
-
$328,718
-
Price per share
-
$1.65
-
Number of holders
-
9
-
Value change
-
+$210,668
-
Number of buys
-
6
-
Number of sells
-
2
Institutional Holders of PALISADE BIO, INC. - Common Stock (PALI) as of Q4 2024
As of 31 Dec 2024,
PALISADE BIO, INC. - Common Stock (PALI) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
199,223 shares.
The largest 9 holders included
ARMISTICE CAPITAL, LLC, Cetera Investment Advisers, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Tower Research Capital LLC (TRC), Federation des caisses Desjardins du Quebec, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, and MORGAN STANLEY.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.